Elattar, Mahmoud Abdelgawad http://orcid.org/0000-0002-3565-0965
Gad, Samah Ahmed
Abd ela-zziz, Amany Mohamed
Elsheikh, Taghreed Salah
Beltagy, Esraa Morshedy
Elgamal, Asmaa Nabil
Elmsri, Hassan Yousef
El refae, Vian Abd el halim
Article History
Received: 17 October 2023
Accepted: 30 November 2023
First Online: 3 January 2024
Declarations
:
: Written informed consent was obtained from the parents.
: The study had been approved by the Ethics Committee of the Ministry of Health and Population, Egypt (Com.No/Dec.No:6-2022/6). Informed consent was obtained from each participant's mother after explaining the purpose, benefits, and potential risks of the study, as well as the right to withdraw at any time without any penalty or loss of benefit. Confidentiality of participants' personal and medical information was strictly maintained by assigning unique codes to each participant's data and storing them in a secure and locked cabinet. The blood samples were collected by trained and licensed medical professionals according to aseptic procedures and without causing any harm or discomfort to the infants. The study followed the principles of the Declaration of Helsinki and the International Conference on Harmonization for Good Clinical Practice.
: Not applicable.
: The authors do not have any relevant financial or non-financial interests to report.